Analyzing Stockanalysis Com: Data-Driven Insights for Investors

Analyzing Stockanalysis Com: Data-Driven Insights for Investors

Stockanalysis com is the domain that routes to one of the most widely used free financial data platforms in the United States, drawing millions of monthly visitors who need quick access to income statements, balance sheets, and valuation ratios without a subscription. The question serious investors ask is not whether the site is popular. It is whether the data is accurate, whether the coverage is deep enough, and whether the analytical gaps matter for the type of decisions they are making.

This post answers those questions with specific evidence, not general impressions.

Key Takeaways

• Stockanalysis com sources its financial data from SEC filings, making it as accurate as the reported numbers for U.S.-listed equities.
• The site covers over 7,000 U.S. tickers and a selection of international markets, with data typically refreshed within one business day of earnings releases.
• Key analytical signals missing from stockanalysis com include: Piotroski F-Score, normalized EBITDA, capital efficiency metrics over time, and any composite quality scoring.
• EV/EBITDA is available on the platform but displayed without normalization or historical range, which limits its utility as a standalone valuation signal.
• The Zacks platform is a direct comparison point: both serve investors seeking free financial data, but with different analytical depth and data organization.
• A structured research workflow that starts with stockanalysis com and supplements with a composite scoring tool closes the gaps that matter for investment decisions.

The Data Sourcing Question: How Reliable Is Stockanalysis Com?

Stockanalysis com pulls its financial statement data from SEC EDGAR filings, the same primary source used by Bloomberg, FactSet, and institutional data vendors. This means the income statement, balance sheet, and cash flow data for U.S.-listed companies is accurate by definition: if the SEC filing says revenue was $394 billion, stockanalysis com shows $394 billion.

The accuracy question gets more complicated for derived metrics. Ratios like EV/EBITDA require assembling multiple inputs: enterprise value (market cap plus debt minus cash) and EBITDA (operating income plus depreciation and amortization). The risk of error exists at the assembly stage, not the sourcing stage. For the large-cap U.S. names that most investors research, stockanalysis com's derived ratios are accurate to within normal rounding differences.

The more important reliability question is freshness. Financial statements are reported quarterly. The platform refreshes within 24 hours of an earnings release. Valuation ratios update in real time as share prices change. For most investment purposes, this freshness is sufficient.

Coverage Analysis: What Stockanalysis Com Includes and Excludes

U.S. equities: Over 7,000 tickers across NYSE, Nasdaq, and smaller exchanges. Coverage is comprehensive for large and mid-cap names. Small-cap and micro-cap coverage exists but with more gaps in derived metrics and historical depth.

International equities: Coverage includes major European, Asian, and Canadian markets but is considerably thinner than U.S. coverage. Financial data for international names may not match the depth of 10-year U.S. data.

ETFs: The site covers major U.S. ETFs including holdings breakdown, expense ratios, and historical performance. Useful for comparing sector exposures.

What is excluded: Private companies, penny stocks below certain market cap thresholds, many OTC securities, and most closed-end funds.

For value investors focused on U.S. large and mid-cap equities, which describes the majority of screener-driven investment processes, the coverage is adequate.

EV/EBITDA on Stockanalysis Com: The Gap Between Display and Interpretation

EV/EBITDA is one of the most commonly referenced enterprise valuation ratios in fundamental analysis. Stockanalysis com displays it on the summary or ratios page for most U.S. tickers. The number is calculated from the current enterprise value and the trailing 12-month EBITDA from the income statement.

Here is what the display does not address:

Normalization. Reported EBITDA frequently includes one-time items that inflate or deflate the trailing figure. A company that took a $2 billion restructuring charge will show depressed EBITDA for the trailing period. Its normalized EBITDA may be 30% higher. Comparing a normalized EV/EBITDA against a reported one produces a misleading relative valuation.

Historical context. A stock trading at an EV/EBITDA of 14 is either cheap or expensive depending on whether its historical range is 8 to 12 or 18 to 25. Stockanalysis com shows the current number, not the historical distribution. You must either build that context yourself from prior financial statements or use a tool that stores it.

Sector context. Capital-intensive businesses (utilities, energy, industrials) trade at lower EV/EBITDA multiples than asset-light businesses (software, platforms, consumer brands) because their EBITDA-to-free-cash-flow conversion is lower. An EV/EBITDA of 10 in energy is not comparable to an EV/EBITDA of 10 in software.

Without this context, an EV/EBITDA number from stockanalysis com is the starting point for a question, not the answer to one.

The Piotroski F-Score: A Critical Gap in Stockanalysis Com

The Piotroski F-Score assesses the financial integrity of a business across nine binary signals drawn from the financial statements. The signals cover three areas: profitability (4 signals), liquidity and solvency (3 signals), and operating efficiency (2 signals). A company earns a point for each signal it passes. Scores of 8 or 9 indicate strong financial quality. Scores of 0 to 2 signal deteriorating fundamentals.

All the inputs needed to calculate the Piotroski F-Score are available in stockanalysis com's financial statements. The platform does not assemble them into the composite score, which means users must either calculate it manually or find a tool that does.

For context: Johnson & Johnson (JNJ), with a dividend yield of 3.1% and a 30+ year consecutive dividend growth streak, consistently scores 8 on the Piotroski test. That score reflects profitability that is improving, debt loads that are declining, and operating efficiency that is rising. You can verify this from the raw data on stockanalysis com, but you must know to look and know how to calculate.

The ValueMarkers screener surfaces the Piotroski F-Score automatically as part of the Integrity pillar (15% of the VMCI composite weighting), alongside the Altman Z-Score and other balance sheet integrity signals.

What Zacks Com Does Differently

Zacks is the most direct institutional comparison to stockanalysis com. Both serve investors seeking financial data and stock research. The differences are meaningful.

Zacks focuses heavily on earnings estimate revisions and analyst consensus. Its proprietary Zacks Rank is based on earnings estimate momentum, which is a momentum-oriented signal rather than a fundamental quality signal. For value investors, earnings estimate revisions are less central than ROIC, balance sheet integrity, and normalized valuation.

Stockanalysis com does not aggregate analyst estimates in the same way Zacks does, but it is stronger on raw financial statement presentation and data downloadability. For fundamental investors who build their own spreadsheet models, stockanalysis com is the more useful raw data source. For investors who want pre-packaged analyst recommendations, Zacks serves a different purpose.

Neither platform provides the composite quality and value scoring that the VMCI framework delivers.

Building a Two-Platform Research Workflow

The most efficient research process for value investors combines stockanalysis com with a composite scoring platform in a defined sequence.

Phase 1 (5 minutes): Stockanalysis com for financial history. Pull the 10-year income statement and note revenue CAGR, gross margin trend, and free cash flow pattern. This immediately disqualifies businesses with declining fundamentals.

Phase 2 (10 minutes): Stockanalysis com for current ratios. Record P/E, EV/EBITDA, price-to-book, and price-to-FCF. These are your valuation inputs, not your valuation conclusion.

Phase 3 (10 minutes): ValueMarkers screener for composite scoring. Run the same ticker through the VMCI framework. Check the Value pillar (35%) for how the current valuation compares to intrinsic value estimates. Check the Quality pillar (30%) for ROIC trend. Check the Integrity pillar (15%) for Piotroski and Altman scores. Check Growth (12%) and Risk (8%) for the tail signals.

This three-phase workflow takes 25 minutes and covers every dimension that matters for a buy-or-pass decision at the initial screening stage.

Price-to-Book on Stockanalysis Com: When It Is and Is Not Useful

Price-to-book is one of the most misused ratios in fundamental analysis. Stockanalysis com shows current price-to-book cleanly, but the metric requires significant interpretation.

For asset-heavy businesses where book value reflects tangible assets at fair market value, price-to-book is a meaningful valuation signal. Berkshire Hathaway (BRK.B) at a price-to-book near 1.5 represents Warren Buffett's own assessment of when BRK.B is cheap enough to buy back shares. When the stock trades below 1.3x book, he has historically repurchased aggressively.

For asset-light businesses where book value is mostly goodwill from acquisitions, price-to-book is nearly meaningless. Microsoft (MSFT) trades at a price-to-book above 12. That number does not signal that MSFT is overpriced. It signals that MSFT's value is almost entirely in its software platforms, cloud infrastructure, and IP, none of which appear on the balance sheet at current market value.

Stockanalysis com shows the P/B ratio but does not distinguish between these two cases. The investor must apply that judgment.

How to Apply the Two-Platform Workflow to a Real Example

Take Johnson & Johnson (JNJ) as a concrete case. The two-platform workflow runs as follows.

Phase 1 on stockanalysis com: pull the 10-year income statement. Revenue grew from $76 billion in 2015 to $88 billion in 2024, with consistent operating margins between 18% and 22%. Net income showed one anomalous year due to litigation charges. Free cash flow was positive and growing in 9 of 10 years.

Phase 2 on stockanalysis com: record current ratios. P/E near 15, EV/EBITDA near 10, price-to-book near 4.2, dividend yield at 3.1%. These numbers place JNJ in the lower half of its healthcare peer valuation range.

Phase 3 on ValueMarkers: run JNJ through the VMCI framework. The Integrity pillar (15% weight) captures the Piotroski F-Score of 8, which reflects improving profitability, declining debt loads, and rising efficiency over the past year. The Quality pillar (30%) shows consistent ROIC above 15%. Combined, JNJ scores above 68 on the VMCI framework, which signals a high-quality business at a fair price for long-term investors.

That three-phase process, starting with the raw data from stockanalysis com and ending with a composite score from our screener, takes roughly 20 minutes and produces a defensible buy-or-pass judgment grounded in specific data.

Further reading: SEC Investor.gov · FINRA

Why stock data reliability Matters

This section anchors the discussion on stock data reliability. The detailed treatment, formula, and worked examples appear in the body of this article above. The points below summarize the most important takeaways for value investors who want to apply stock data reliability in real portfolio decisions. ValueMarkers exposes the underlying data on every covered ticker via the screener and stock profile pages, so the concepts in this article translate directly into actionable filters.

Key inputs for stock data reliability

See the main discussion of stock data reliability in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using stock data reliability alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.

Sector benchmarks for stock data reliability

See the main discussion of stock data reliability in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using stock data reliability alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.

Related ValueMarkers Resources

• Enterprise Value to EBITDA (EV/EBITDA) — Enterprise Value to EBITDA is the metric used to how cheaply a stock trades relative to its fundamentals
• Pb Ratio — Glossary entry for Pb Ratio
• Piotroski F-Score — Piotroski F-Score captures the reliability of reported earnings versus underlying cash flow
• Stock Analysiscom — related ValueMarkers analysis
• Stockanalysis — related ValueMarkers analysis
• Power Etrade Stock Screener — related ValueMarkers analysis

Frequently Asked Questions

what is zacks com

Zacks.com is a financial research platform founded in 1978 by Len Zack, focused primarily on earnings estimate revisions and analyst consensus. Its proprietary Zacks Rank assigns stocks a score from 1 (Strong Buy) to 5 (Strong Sell) based on changes in earnings estimate consensus, a momentum-based signal rather than a fundamental value signal. Zacks also offers screeners, ETF analysis, and portfolio tools. It serves a different analytical purpose than stockanalysis com, which focuses on raw financial statement data rather than analyst forecast aggregation.

is stock analysis com reliable

Stock analysis com is reliable for U.S. financial statement data because it sources directly from SEC EDGAR filings, the same primary source used by institutional data providers. Derived metrics like EV/EBITDA are accurate for most large-cap U.S. names within standard rounding differences. The reliability drops for international equities, small-cap stocks, and any metric that requires normalization of reported figures. For investment decisions, use the raw financial statements as reliable inputs and apply your own normalization and analytical framework.

What is stockanalysis com?

Stockanalysis com is a free financial data website that provides income statements, balance sheets, cash flow statements, and standard valuation ratios for U.S.-listed equities and a selection of international markets. Launched in 2017, it serves investors who need quick access to 10 years of financial history without the cost of a Bloomberg or FactSet subscription. A premium tier adds extended data history, API access, and portfolio tracking at a substantially lower price than institutional alternatives.

How do you calculate stockanalysis com?

Stockanalysis com is a website that retrieves and displays financial data, not a single formula. The platform calculates standard ratios from SEC filing data: EV/EBITDA equals enterprise value divided by trailing EBITDA, P/E equals share price divided by earnings per share, and price-to-book equals share price divided by book value per share. Investors can download the underlying financial statements as CSV files to run their own calculations from the raw inputs.

Why is stockanalysis com important for investors?

Stockanalysis com significantly reduces the time required to build a 10-year financial history of a business. Without it, an investor researching Apple (AAPL) would need to download 10 annual 10-K filings from the SEC and manually extract the relevant income statement and balance sheet lines. The platform centralizes that data in a consistent format that takes seconds to access. That time saving is real and meaningful for any investor who screens across multiple companies in a session.

How to use stockanalysis com in stock analysis?

Start with the 10-year income statement to assess revenue and margin trends. Move to the balance sheet to check debt levels and liquidity. Review the cash flow statement to confirm that reported earnings convert to real cash. Pull the current ratios as valuation inputs. Then supplement with a tool that provides composite quality scoring, normalized valuations, and analytical signals the platform does not calculate. This structured sequence takes roughly 25 minutes per company and covers all the dimensions that matter for an initial screening decision.

Compare stockanalysis com against other platforms on the metrics that matter most for your research process at our comparison tool.

Written by Javier Sanz, Founder of ValueMarkers. Last updated April 2026.

Ready to find your next value investment?

ValueMarkers tracks 120+ fundamental indicators across 100,000+ stocks on 73 global exchanges. Run the methodology above in seconds with our stock screener, or see today's top-ranked names on the leaderboard.

Related tools: DCF Calculator · Methodology · Compare ValueMarkers

Disclaimer: This content is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.